Gary W Falk
Affiliation: University of Pennsylvania
- Clinical presentation of eosinophilic esophagitis in adultsGary W Falk
Division of Gastroenterology, Hospital of the University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, 9 Penn Tower, One Convention Avenue, Philadelphia, PA 19104, USA Electronic address
Gastroenterol Clin North Am 43:231-42. 2014..Despite the increasing awareness of EoE among practicing physicians, a long delay from onset of symptoms to diagnosis remains a problem in this disease. ..
- Update on ablation for Barrett's esophagusGary W Falk
Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, 9 Penn Tower, One Convention Avenue, Philadelphia, PA, 19104, USA
Curr Gastroenterol Rep 16:368. 2014..Studies are underway to help determine predictors of response and recurrence. ..
- A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagusGary W Falk
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Gastroenterology 143:917-26.e1. 2012....
- Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagusMohammad Titi
Division of Gastroenterology, Veterans Affairs Medical Center, University of Kansas School of Medicine, 4801 East Linwood Boulevard, Kansas City, Missouri 64128, USA
Gastroenterology 143:564-6.e1. 2012....
- Location, location, location: does early cancer in Barrett's esophagus have a preference?Brintha K Enestvedt
Department of Medicine, Division of Gastroenterology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA
Gastrointest Endosc 78:462-7. 2013..Early cancer (high-grade dysplasia [HGD] and intramucosal carcinoma [ImCa]) associated with Barrett's esophagus (BE) may have a circumferential spatial predilection...
- Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradicationCarlos Guarner-Argente
Department of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Gastrointest Endosc 77:190-9. 2013..Endoluminal therapy is an option for selected patients with Barrett's esophagus and high-grade dysplasia or early cancer...
- Barrett's esophagus surveillance: When, how often, does it work?Bryson W Katona
Department of Internal Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 100 Centrex, Philadelphia, PA 19104, USA
Gastrointest Endosc Clin N Am 21:9-24. 2011....
- Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagusAmitabh Chak
Division of Gastroenterology, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA
Cancer Epidemiol Biomarkers Prev 21:376-83. 2012..In this study, we determine whether cancers develop at an earlier age in multiplex Familial Barrett's Esophagus (FBE) kindreds, defined by 3 or more members affected by Barrett's esophagus (BE) or esophageal adenocarcinoma (EAC)...
- Subsquamous intestinal metaplasia: implications for endoscopic management of Barrett's esophagusPatrick Yachimski
Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee 37232 5280, USA
Clin Gastroenterol Hepatol 10:220-4. 2012....
- Modeling human gastrointestinal inflammatory diseases using microphysiological culture systemsKira G Hartman
Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Exp Biol Med (Maywood) 239:1108-23. 2014....
- Barrett's esophagus: prevalence-incidence and etiology-originsGary W Falk
Department of Medicine, Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Ann N Y Acad Sci 1232:1-17. 2011..Gastroesophageal reflux disease may be considered an immune-mediated disease starting at the submucosal layer; the cytokine profile of the mucosal immune response may explain the different outcome of gastroesophageal reflux...